Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-485-5 | CAS number: 939402-02-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
Introduction: The study was desgined to investigate the systemic toxicity and potential adverse effects on reproduction (including offspring development) of the test item and complies with the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 "Reproduction/Developmental Toxicity Screening Test" (adopted 27 July 1995).
Methods: The test item was administered by gavage to three groups each of ten male and ten female Wistar Han TM: WIST strain rats, for up to fifty four days, at dose levels of 100, 300 and 1000 mg/kg/day. A control group of ten males and ten females were dose with vehicle alone. (Arachis oil).
Clinical signs, body weight development, food and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis on Day 15 of the study, to produce litters. During the lactation phase, daily clinical observations werte undertaken on all live offspring, together with litter size, offspring weights and assesment of developmental landmarks.
Males were terminated on Day 43, followed by termination of females and offspring on Day 5 post partum. All animals were subjected to a gross necropsy examination and preliminary histopathological evaluation was undertaken.
Results:
Mortality: There were no unscheduled deaths during the study.
Clinical Observations: There were no clinical signs of toxicity detected.
Body Weight: No adverse effects on body weight development were detected for all treated animals or recovery animals during the treatment free period when compared to controls.
Food Consumption:No adverse effects on food intake or food efficiency were detected.
Water Consumption: No intergroup differences were detected.
Reproductive Performance:
Mating:
There were no toxicologically significant effects on mating or conception rates for animals of either sex treated with 100, 300 or 1000 mg/kg/day.
One females treated with 1000 mg/kg/day and one females treated with 100 mg/kg/day failed to achieve pregnancy following evidence of mating.
Gestation: There were no differences in gestation length. The distribution for treated females was comparable to controls.
Litter Size and Viability: No differences in corpea lutea, implantation sites, or pre- and post-implantation losses were detected for females from treated groups when compared to controls. Of the litter born, litter size at birth and subsequently on Days 1 and 4 post partum were comparable to controls.
Offspring Growth and Development: No differences in litter weights, offspring weights or surface righting were detected for litters from treated groups when compared to control litters.
Litter Observations: No clinically observable signs of toxicity were detcted for offspring from all treatment groups.
Pathology:
Organ wieghts: No toxicologically significant effects were detected in the organ weights measured.
Necropsy:There were no toxicilogically significant macroscopic abnormalities detected.
Histopathology: There were no treatment-related microscopic effects detected.
Short description of key information:
The study was desgined to investigate the systemic toxicity and potential adverse effects on reproduction (including offspring development) of the test item and complies with the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 "Reproduction/Developmental Toxicity Screening Test" (adopted 27 July 1995).
The study has been ranked reliability 1 according to the scoring system by Klimisch et al. This ranking was deemed appropriate as the study was conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of relevant results.
Effects on developmental toxicity
Description of key information
The study was desgined to investigate the systemic toxicity and potential adverse effects on reproduction (including offspring development) of the test item and complies with the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 "Reproduction/Developmental Toxicity Screening Test" (adopted 27 July 1995).
The study has been ranked reliability 1 according to the scoring system by Klimisch et al. This ranking was deemed appropriate as the study was conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of relevant results.
Additional information
Introduction: The study was desgined to investigate the systemic toxicity and potential adverse effects on reproduction (including offspring development) of the test item and complies with the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 "Reproduction/Developmental Toxicity Screening Test" (adopted 27 July 1995).
Methods: The test item was administered by gavage to three groups each of ten male and ten female Wistar Han TM: WIST strain rats, for up to fifty four days, at dose levels of 100, 300 and 1000 mg/kg/day. A control group of ten males and ten females were dose with vehicle alone. (Arachis oil).
Clinical signs, body weight development, food and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis on Day 15 of the study, to produce litters. During the lactation phase, daily clinical observations werte undertaken on all live offspring, together with litter size, offspring weights and assesment of developmental landmarks.
Males were terminated on Day 43, followed by termination of females and offspring on Day 5 post partum. All animals were subjected to a gross necropsy examination and preliminary histopathological evaluation was undertaken.
Results:
Mortality: There were no unscheduled deaths during the study.
Clinical Observations: There were no clinical signs of toxicity detected.
Body Weight: No adverse effects on body weight development were detected for all treated animals or recovery animals during the treatment free period when compared to controls.
Food Consumption:No adverse effects on food intake or food efficiency were detected.
Water Consumption: No intergroup differences were detected.
Reproductive Performance:
Mating:
There were no toxicologically significant effects on mating or conception rates for animals of either sex treated with 100, 300 or 1000 mg/kg/day.
One females treated with 1000 mg/kg/day and one females treated with 100 mg/kg/day failed to achieve pregnancy following evidence of mating.
Gestation: There were no differences in gestation length. The distribution for treated females was comparable to controls.
Litter Size and Viability: No differences in corpea lutea, implantation sites, or pre- and post-implantation losses were detected for females from treated groups when compared to controls. Of the litter born, litter size at birth and subsequently on Days 1 and 4 post partum were comparable to controls.
Offspring Growth and Development: No differences in litter weights, offspring weights or surface righting were detected for litters from treated groups when compared to control litters.
Litter Observations: No clinically observable signs of toxicity were detcted for offspring from all treatment groups.
Pathology:
Organ wieghts: No toxicologically significant effects were detected in the organ weights measured.
Necropsy:There were no toxicilogically significant macroscopic abnormalities detected.
Histopathology: There were no treatment-related microscopic effects detected.
Justification for classification or non-classification
The submission substance did not meet the criteria for classification as regards impairing fertility or reproduction, or causing harm to the unborn child.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2